5 completed, 3 terminated. 6 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 2 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Cell Medica Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas baltaleucel-T - Hodgkin Lymphoma, Lymphoma, Large B-Cell, Diffuse | Phase 2 | Terminated | Cell Medica Ltd | 1 | 2016-11-01 | 2019-03-26 |
| Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT antiviral therapies for CMV and/or ADV - Infectious Complications Following HSCT | Terminated | Cell Medica Ltd | 1 | 2016-05-11 | 2018-02-01 | |
| A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients Autologous WT1 TCR transduced T cells - Myelodysplastic Syndromes (MDS), Acute Myeloid Leukaemia (AML) | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 3 | 2015-09-01 | 2018-10-02 |
| Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma baltaleucel-T - Lymphoma, Extranodal NK-T-Cell, EBV | Phase 2 | Terminated | Cell Medica Ltd | 15 | 2014-09-01 | 2019-03-13 |
| Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT Cytovir-ADV - ADV Infection Post Allo-HSCT | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 8 | 2012-12-01 | 2018-01-25 |
| WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study WT1 TCR-transduced T cells - Acute Myeloid Leukaemia, Chronic Myeloid Leukaemia | Phase 1 / Phase 2 | Completed | Cell Medica Ltd | 7 | 2012-04-01 | 2018-10-02 |
| Alternate Donor Study of Pre-Emptive Cellular Therapy CMV-specific T-cells, single infusion following single positive CMV PCR result - Cytomegalovirus Infection | Phase 2 | Completed | Cell Medica Ltd | 52 | 2010-10-01 | 2018-01-25 |
| Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study Adoptive Cellular Therapy, Best available antiviral drug therapy - Cytomegalovirus Infection | Phase 3 | Completed | Cell Medica Ltd | 89 | 2008-07-01 | 2018-01-25 |
Cytomegalovirus Infections (2) · Epstein-Barr Virus Infections (2) · Leukemia, Myeloid, Acute (2) · Hodgkin Disease (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Myelodysplastic Syndromes (1)
United Kingdom (7) · United States (2) · Belgium (1) · France (1) · Germany (1) · South Korea (1)
Karl S Peggs (2) · Kurt Gunter, MD (2) · Emma Morris, Dr (1) · Emma Morris, MD (1) · Helen Heslop, MD (1) · Prashant Hiwarkar (1) · Waseem Qasim (1)